Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade
- 1 November 2014
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 27 (11) , 1521-1539
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term SurvivalGastroenterology Research and Practice, 2012
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyJournal of Clinical Oncology, 2012
- Pathology and prognosis in pseudomyxoma peritonei: a review of 274 casesJournal of Clinical Pathology, 2012
- Ki-rasgene mutations are invariably present in low-grade mucinous tumors of the vermiform appendixScandinavian Journal of Gastroenterology, 2011
- Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal originJournal of Surgical Oncology, 2010
- Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapyEuropean Journal of Surgical Oncology, 2010
- Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal originCancer, 2009
- Appendiceal Mucinous NeoplasmsAmerican Journal of Surgical Pathology, 2009
- Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Annals of Surgical Oncology, 2007
- A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma PeritoneiAnnals of Surgical Oncology, 2006